Skip to main content
. 2020 Mar 19;2020(3):CD012517. doi: 10.1002/14651858.CD012517.pub2

NCT02716818.

Trial name or title Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal Hyperplasia
Methods Phase 3, open‐label RCT.
Location: USA.
Duration: 6 months.
Participants 122 participants.
Age: > 18 years.
Gender: females and males both eligible.
Diagnosis: classical CAH due to 21‐hydroxylase deficiency.
Interventions Arm 1: HC.
Arm 2: PD alone or PD and HC.
Arm 3: DXA only or in combination with a different glucocorticoid.
Outcomes Primary: change from baseline 17 OHP.
Secondary: change in DEXA scan.
Starting date February 2016.
Contact information Debbie Merke, MD.
Notes Sponsored by Diurnal Ltd.